Alignment Healthcare, Inc. (ALHC)
NASDAQ: ALHC · Real-Time Price · USD
19.55
+0.15 (0.77%)
At close: Dec 5, 2025, 4:00 PM EST
19.21
-0.34 (-1.74%)
After-hours: Dec 5, 2025, 5:23 PM EST
Alignment Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Premiums & Annuity Revenue | 3,600 | 2,672 | 1,801 | 1,432 | 1,167 | 955.39 | Upgrade
|
| Other Revenue | 37.44 | 31.63 | 22.7 | 2.61 | 0.69 | 3.83 | Upgrade
|
| Total Revenue | 3,637 | 2,704 | 1,824 | 1,434 | 1,168 | 959.22 | Upgrade
|
| Revenue Growth (YoY) | 47.39% | 48.25% | 27.16% | 22.81% | 21.74% | 26.72% | Upgrade
|
| Policy Benefits | 3,186 | 2,407 | 1,623 | 1,250 | 1,039 | 792.99 | Upgrade
|
| Depreciation & Amortization | 28.1 | 26.27 | 21.41 | 17.27 | 15.81 | 15.1 | Upgrade
|
| Selling, General & Administrative | 416.86 | 368.89 | 307.43 | 295.65 | 290.99 | 156.4 | Upgrade
|
| Total Operating Expenses | 3,631 | 2,802 | 1,951 | 1,563 | 1,346 | 964.49 | Upgrade
|
| Operating Income | 6.64 | -98.48 | -127.82 | -128.64 | -178.07 | -5.26 | Upgrade
|
| Interest Expense | -17.34 | -23.55 | -21.23 | -18.29 | -17.44 | -16.93 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.08 | 0.21 | 0.56 | 0.44 | 0.23 | 0.27 | Upgrade
|
| EBT Excluding Unusual Items | -10.63 | -121.82 | -148.48 | -146.49 | -195.29 | -21.92 | Upgrade
|
| Merger & Restructuring Charges | -1.57 | -1.57 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.15 | 0.01 | 0.29 | -0.1 | - | -1.01 | Upgrade
|
| Asset Writedown | -0.74 | -0.74 | - | -0.51 | - | - | Upgrade
|
| Legal Settlements | -1.34 | -0.91 | - | - | - | - | Upgrade
|
| Other Unusual Items | -3.02 | -3.02 | - | -2.2 | - | - | Upgrade
|
| Pretax Income | -17.78 | -128.05 | -148.2 | -149.3 | -195.29 | -22.93 | Upgrade
|
| Income Tax Expense | 3.25 | 0.02 | -0.02 | 0.34 | - | - | Upgrade
|
| Earnings From Continuing Ops. | -21.04 | -128.07 | -148.17 | -149.64 | -195.29 | -22.93 | Upgrade
|
| Minority Interest in Earnings | 0.23 | 0.04 | 0.16 | 0.09 | - | - | Upgrade
|
| Net Income | -20.81 | -128.04 | -148.02 | -149.55 | -195.29 | -22.93 | Upgrade
|
| Net Income to Common | -20.81 | -128.04 | -148.02 | -149.55 | -195.29 | -22.93 | Upgrade
|
| Shares Outstanding (Basic) | 196 | 191 | 186 | 181 | 172 | 152 | Upgrade
|
| Shares Outstanding (Diluted) | 196 | 191 | 186 | 181 | 172 | 152 | Upgrade
|
| Shares Change (YoY) | 3.06% | 2.46% | 2.76% | 5.38% | 13.03% | 11.97% | Upgrade
|
| EPS (Basic) | -0.11 | -0.67 | -0.79 | -0.83 | -1.14 | -0.15 | Upgrade
|
| EPS (Diluted) | -0.11 | -0.67 | -0.79 | -0.83 | -1.14 | -0.15 | Upgrade
|
| Free Cash Flow | 150.56 | -6.65 | -95.18 | -69.2 | -98.54 | -8.15 | Upgrade
|
| Free Cash Flow Per Share | 0.77 | -0.04 | -0.51 | -0.38 | -0.57 | -0.05 | Upgrade
|
| Operating Margin | 0.18% | -3.64% | -7.01% | -8.97% | -15.25% | -0.55% | Upgrade
|
| Profit Margin | -0.57% | -4.74% | -8.12% | -10.43% | -16.72% | -2.39% | Upgrade
|
| Free Cash Flow Margin | 4.14% | -0.25% | -5.22% | -4.83% | -8.44% | -0.85% | Upgrade
|
| EBITDA | 35.46 | -71.41 | -106.15 | -111.15 | -162.04 | 10.2 | Upgrade
|
| EBITDA Margin | 0.97% | -2.64% | -5.82% | -7.75% | -13.88% | 1.06% | Upgrade
|
| D&A For EBITDA | 28.82 | 27.06 | 21.67 | 17.49 | 16.03 | 15.46 | Upgrade
|
| EBIT | 6.64 | -98.48 | -127.82 | -128.64 | -178.07 | -5.26 | Upgrade
|
| EBIT Margin | 0.18% | -3.64% | -7.01% | -8.97% | -15.25% | -0.55% | Upgrade
|
| Revenue as Reported | 3,637 | 2,704 | 1,824 | 1,434 | 1,168 | 959.22 | Upgrade
|
Source: S&P Capital IQ. Insurance template. Financial Sources.